Imperial College London

ProfessorDarrelFrancis

Faculty of MedicineNational Heart & Lung Institute

Professor of Cardiology
 
 
 
//

Contact

 

+44 (0)20 7594 3381d.francis Website

 
 
//

Assistant

 

Miss Juliet Holmes +44 (0)20 7594 5735

 
//

Location

 

Block B Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Bouri:2014:10.1136/heartjnl-2013-304262,
author = {Bouri, S and Shun-Shin, MJ and Cole, GD and Mayet, J and Francis, DP},
doi = {10.1136/heartjnl-2013-304262},
journal = {Heart},
pages = {456--464},
title = {Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery},
url = {http://dx.doi.org/10.1136/heartjnl-2013-304262},
volume = {100},
year = {2014}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Background Current European and American guidelines recommend the perioperative initiation of a course of β-blockers in those at risk of cardiac events undergoing high- or intermediate-risk surgery or vascular surgery. The Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography (DECREASE) family of trials, the bedrock of evidence for this, are no longer secure. We therefore conducted a meta-analysis of randomised controlled trials of β-blockade on perioperative mortality, non-fatal myocardial infarction, stroke and hypotension in non-cardiac surgery using the secure data.Methods The randomised controlled trials of initiation of β-blockers before non-cardiac surgery were examined. Primary outcome was all-cause mortality at 30days or at discharge. The DECREASE trials were separately analysed.Results Nine secure trials totalling 10529 patients, 291 of whom died, met the criteria. Initiation of a course of β-blockers before surgery caused a 27% risk increase in 30-day all-cause mortality (p=0.04). The DECREASE family of studies substantially contradict the meta-analysis of the secure trials on the effect of mortality (p=0.05 for divergence). In the secure trials, β-blockade reduced non-fatal myocardial infarction (RR 0.73, p=0.001) but increased stroke (RR 1.73, p=0.05) and hypotension (RR 1.51, p<0.00001). These results were dominated by one large trial.Conclusions Guideline bodies should retract their recommendations based on fictitious data without further delay. This should not be blocked by dispute over allocation of blame. The well-conducted trials indicate a statistically significant 27% increase in mortality from the initiation of perioperative β-blockade that guidelines currently recommend. Any remaining enthusiasts might best channel their energy into a further randomised trial which should be designed carefully and conducted honestly.
AU - Bouri,S
AU - Shun-Shin,MJ
AU - Cole,GD
AU - Mayet,J
AU - Francis,DP
DO - 10.1136/heartjnl-2013-304262
EP - 464
PY - 2014///
SN - 1355-6037
SP - 456
TI - Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery
T2 - Heart
UR - http://dx.doi.org/10.1136/heartjnl-2013-304262
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331610400006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://hdl.handle.net/10044/1/61359
VL - 100
ER -